© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2010 (No. PB 117 of 2010)
Start here
Turn the raw legal text into a practical explanation grounded in National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2010 (No. PB 117 of 2010).
15 Authority required procedures — submission of paragraph 10 (1) (b) medication chart
(1) If subsection 12 (3) applies to a medication chart prepared in accordance with paragraph 10 (1) (b) for the supply of a chemotherapy pharmaceutical benefit, a pharmacist employed by the approved hospital authority must, on behalf of the eligible medical practitioner, submit the information mentioned in section 11 to the Chief Executive Medicare by means of an electronic communication of a kind approved by the Chief Executive Medicare.
(2) If a circumstance mentioned in paragraph (3) (a) or (b) applies, an authorisation for the supply of the chemotherapy pharmaceutical benefit may be obtained if the eligible medical practitioner prepares a prescription in accordance with paragraph 10 (1) (a) and submits that prescription in accordance with section 13 for authorisation under section 14.
(3) For subsection (2), the circumstances are:
(a) the pharmacist attempted to submit the information in accordance with subsection (1) but was unable to do so because the system established by the Chief Executive Medicare for the provision of such authorisation was unavailable; or
(b) the pharmacist submitted the information in accordance with subsection (1) but the authorisation was not granted by the system established by the Chief Executive Medicare.